Regencell Bioscience Financial Overview
Regencell Bioscience's market cap is currently $8.31B. The company's EPS TTM is $-0.33; its P/E ratio is -2,627.78; Regencell Bioscience is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.